Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-05

Clinical Trial Update: Empirical Radioactive Iodine Therapy in DTC [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for empirical radioactive iodine therapy in differentiated thyroid cancer, spanning Phase 1 and Phase 2, not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Radioactive iodine (I-131) (iodine-131)

Snippet

Sponsor: Assiut University | Conditions: Differentiated Thyroid Cancer | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING